FDA authorizes COVID-19 vaccine booster doses for younger age groups
WASHINGTON, Oct 12: The US Food and Drug Administration (FDA) amended Wednesday the emergency use authorizations (EUAs) of the Moderna and Pfizer Bivalent COVID-19s “to authorize their use as a … Read More